https://www.fiercebiotech.com/biotech/biotech-creator-and-chinas-keymed-launch-company-180m-series-cd38-targetting-antibody
Mountainfield, China's Keymed launch biotech with $180M series A
Jan 10, 2025 - The new company, called Timberlyne Therapeutics, will be centered around the IgG1 monoclonal antibody CM313.
chinalaunchbiotechseries
https://mountainfieldvp.com/
Home - Mountainfield Venture Partners
Oct 3, 2025 - Biopharma Company Creation Breakthrough medicines.Breakout companies. Mountainfield About Us Mountainfield builds new companies around development-stage...
venturepartners